Compare Agilent Technologies Inc (A) vs Honeywell International Inc (HON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Honeywell International Inc — how do they compare? Agilent Technologies Inc trades at $140.58 (market cap $38.94B), while Honeywell International Inc trades at $246.55 (market cap $77.89B). The key difference: Honeywell International Inc is far larger — about 2× Agilent Technologies Inc's market cap, and Honeywell International Inc pays the higher dividend (1.14%). Which is the better fit depends on your goals.
| A | HON | |
|---|---|---|
Market Cap | $38.94B | $77.89B |
Sector | Health | Industrials |
52-Week High | $157.20 | $248.04 |
52-Week Low | $110.24 | $188.14 |
Enterprise Value | $40.49B | $102.68B |
Dividend Yield | 0.74% | 1.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $140.60, up 1.46% in the last session, with a bullish technical signal and strong analyst support. Recent earnings beat expectations in Q1 2026, and the company maintains robust profitability with a net margin of 19.55%. Key developments include FDA and EU approvals for diagnostic tools and the acquisition of Biocare Medical, enhancing its biopharma portfolio.
The outlook remains positive given solid fundamentals, growth initiatives in AI and diagnostics, and a consensus price target of $154.90. Risks include execution challenges from acquisitions and macroeconomic pressures on R&D spending. The stock offers upside potential but requires monitoring of integration progress and market conditions.
Honeywell (HON) trades at $247.05, up 1.6% today, with a bullish technical signal and strong analyst consensus. Recent Q2 2026 earnings beat expectations, driven by automation growth and portfolio simplification post-spinoffs. Key financials show robust profitability with a 21.58% net margin and 47.43% ROE, though revenue dipped slightly in 2025. The stock is near its pivot point of $245, with resistance at $248.
Outlook is positive with a $320.54 consensus price target, supported by raised guidance and strategic focus on automation. Risks include debt increase and macroeconomic pressures. Institutional sentiment leans bullish, but overbought RSI levels suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →
